home / stock / trpx / trpx quote
Last: | $0.317 |
---|---|
Change Percent: | -48.9% |
Open: | $0.3626 |
Close: | $0.317 |
High: | $0.3999 |
Low: | $0.3011 |
Volume: | 6,962,700 |
Last Trade Date Time: | 07/01/2020 04:56:03 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.317 | $0.3626 | $0.317 | $0.3999 | $0.3011 | 6,962,700 | 07-01-2020 |
$0.6204 | $0.6 | $0.6204 | $0.63 | $0.569 | 766,202 | 06-30-2020 |
$0.6031 | $0.68 | $0.6031 | $0.68 | $0.55 | 2,057,771 | 06-29-2020 |
$0.7173 | $0.798 | $0.7173 | $0.798 | $0.7111 | 494,309 | 06-26-2020 |
$0.75 | $0.7 | $0.75 | $0.785 | $0.691 | 853,752 | 06-25-2020 |
$0.7089 | $0.7345 | $0.7089 | $0.7345 | $0.69 | 434,454 | 06-24-2020 |
$0.73 | $0.76 | $0.73 | $0.7764 | $0.7 | 616,803 | 06-23-2020 |
$0.7584 | $0.7375 | $0.7584 | $0.82 | $0.6811 | 1,119,305 | 06-22-2020 |
$0.75 | $0.66 | $0.75 | $0.7628 | $0.6321 | 1,720,272 | 06-19-2020 |
$0.669 | $0.6758 | $0.669 | $0.68 | $0.631 | 1,012,716 | 06-18-2020 |
$0.6799 | $0.705 | $0.6799 | $0.75 | $0.65 | 1,280,201 | 06-17-2020 |
$0.705 | $0.75 | $0.705 | $0.7697 | $0.7 | 940,021 | 06-16-2020 |
$0.76 | $0.7201 | $0.76 | $0.8 | $0.67 | 1,940,631 | 06-15-2020 |
$0.604 | $0.63 | $0.604 | $0.6499 | $0.57 | 332,660 | 06-11-2020 |
$0.646 | $0.71 | $0.646 | $0.71 | $0.63 | 1,041,890 | 06-10-2020 |
$0.699 | $0.67 | $0.699 | $0.84 | $0.62 | 4,338,486 | 06-09-2020 |
$0.69 | $0.69 | $0.69 | $0.714 | $0.6619 | 2,046,628 | 06-08-2020 |
$0.6642 | $0.575 | $0.6642 | $0.75 | $0.5504 | 6,009,832 | 06-05-2020 |
$0.55 | $0.54 | $0.55 | $0.5899 | $0.5 | 2,290,594 | 06-04-2020 |
$0.52 | $0.495 | $0.52 | $0.5598 | $0.46 | 3,260,827 | 06-03-2020 |
News, Short Squeeze, Breakout and More Instantly...
Therapix Biosciences Ltd. Company Name:
TRPX Stock Symbol:
NASDAQ Market:
TEL AVIV, Israel , Aug. 21, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today the replacement of its board of directors. The Comp...
TEL AVIV, Israel , July 9, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today that its American Depositary Shares ("ADSs") will no...
TEL AVIV, Israel , July 1, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) (the "Company" or "Therapix"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today receipt of Notice of Delisting and Inju...